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Abstract
Notwithstanding the well-characterised roles of a number of oncogenes in neoplastic transformation, microRNAs (miRNAs)
are increasingly implicated in several human cancers. Discovery of miRNAs in several oncogenic herpesviruses such as KSHV
has further highlighted the potential of virus-encoded miRNAs to contribute to their oncogenic capabilities. Nevertheless,
despite the identification of several possible cancer-related genes as their targets, the direct in vivo role of virus-encoded
miRNAs in neoplastic diseases such as those induced by KSHV is difficult to demonstrate in the absence of suitable models.
However, excellent natural disease models of rapid-onset Marek’s disease (MD) lymphomas in chickens allow examination of
the oncogenic potential of virus-encoded miRNAs. Using viruses modified by reverse genetics of the infectious BAC clone of
the oncogenic RB-1B strain of MDV, we show that the deletion of the six-miRNA cluster 1 from the viral genome abolished
the oncogenicity of the virus. This loss of oncogenicity appeared to be primarily due to the single miRNA within the cluster,
miR-M4, the ortholog of cellular miR-155, since its deletion or a 2-nucleotide mutation within its seed region was sufficient
to inhibit the induction of lymphomas. The definitive role of this miR-155 ortholog in oncogenicity was further confirmed by
the rescue of oncogenic phenotype by revertant viruses that expressed either the miR-M4 or the cellular homolog gga-miR-
155. This is the first demonstration of the direct in vivo role of a virus-encoded miRNA in inducing tumors in a natural
infection model. Furthermore, the use of viruses deleted in miRNAs as effective vaccines against virulent MDV challenge,
enables the prospects of generating genetically defined attenuated vaccines.
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Introduction
Oncogenic viruses account for nearly a fifth of all human
cancers [1]. In addition to their devastating effects on human
health, virus-induced neoplastic diseases are valuable models in
understanding the molecular pathways and dynamics of cancer.
Although most of the past studies on the molecular mechanisms of
cancer induced by oncogenic viruses have primarily centred on
classic oncogenes [2], increasing demonstration of the widespread
role of micro(mi)RNAs in cancer has added new dimensions to the
molecular mechanisms of neoplastic transformation [3,4]. More-
over, the identification of miRNAs encoded by human oncogenic
viruses such as Kaposi’s sarcoma-associated herpesvirus (KSHV)
and Epstein-Barr virus (EBV) suggested that virus-encoded
miRNAs may also contribute towards the oncogenicity of the
virus. The potential of some of these miRNAs to target a number
of host genes associated with the oncogenic pathways has further
strengthened the case for their role in inducing malignancies [5,6].
However, despite the identification of several potential targets [7],
direct in vivo role of virus-encoded miRNAs in the induction of
malignancies is yet to be demonstrated, due at least in part, to the
absence of suitable animal disease models.
Marek’s disease (MD), a naturally occurring neoplastic disease
of poultry [8], is an excellent model for herpesvirus-induced
lymphomas [9,10,11,12]. All birds exposed to the causative
Marek’s disease virus (MDV), unless protected by vaccination or
have genetic resistance to the disease, develop rapid-onset T-cell
lymphomas usually from 3–4 weeks after infection. Among the
virus-encoded genes, Meq protein encoded from the MDV EcoRI
Q fragment is considered to be primarily associated with the
oncogenicity of the virus, since its deletion [13] or inhibition of its
interaction with host proteins such as c-Jun, c-Fos and C-terminal
binding protein [11,14,15] can abolish the oncogenic potential of
the virus. Although these studies clearly demonstrate the
contribution of Meq in oncogenesis, other viral genes could also
be important in the induction of MD lymphomas. We and others
have shown that MDV also encodes 14 miRNAs located within
three clusters from each of the long (IRL/TRL) and short (IRS/
TRS) repeat regions of the viral genome [16,17]. Most of these
miRNAs are expressed at high levels in MD lymphomas and
transformed T-cell lines [18] suggesting their direct role in
transformation. The six miRNAs in cluster 1, thought to be
processed from a single primary transcript upstream of the Meq
locus [16] included miR-M4, the functional ortholog of miR-155
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recently been shown to inhibit the translation of viral proteins
involved in the cleavage and packaging of herpesvirus DNA [22].
However, based on the direct association of miR-155 in several
cancers [23,24], including the recent findings on its roles in TGF-b
pathway and lymphomagenesis [25] and modulation of mismatch
repair and genomic instability [26], we hypothesised that miR-M4
has a major role in MDV oncogenicity. This was also supported by
recent observations of high levels of its expression in tumors
correlated with the pathogenicity of viral strains [17].
In the present study, we explored the functional role of the
miRNAs encoded within the cluster 1 of the MDV genome,
including that of the miR-155 functional ortholog miR-M4, in
inducing T-cell lymphomas using the well-established models of
MD in the natural chicken hosts of the virus. Using a series of
mutant viruses generated by reverse genetics techniques [27,28] on
the full-length infectious bacterial artificial chromosome (BAC)
clone of the highly oncogenic RB-1B virus [29,30], we were able to
directly examine the in vivo functions of MDV-encoded miRNAs in
the induction of MD lymphomas. Our studies demonstrate the
critical role of the cluster 1 miRNAs, especially of the miR-M4, in
the induction of lymphomas, thus providing the direct evidence on
the in vivo function of miRNAs in virus-induced cancer.
Results
Cluster 1 miRNAs are not essential for MDV replication
Members of the Family Herpesviridae account for most of the
currently identified virus-encoded miRNAs, and these are thought
to play important roles in the distinct biological and pathogenic
features of these viruses. MDV encoded-miRNAs are expressed as 3
clusters from the repeat regions, making each miRNA present as
two identical copies in the viral genome (Fig. 1). We have previously
demonstrated high levels of expression of these miRNAs both in vitro
andinvivo[16,31].However,thesestudiesdidnotshowwhetherany
of these miRNAs are essential for viral replication. In order to
address this, we examined the role of cluster 1 miRNAs using a
series of mutant viruses generated by reverse genetics techniques on
the pRB-1B5 BAC clone [29]. In the mutant virus construct miR-
00, the region encoding the miRNA cluster and the overlapping R-
LORF8 in the TRL or IRL regions were deleted by recombination
using galK-kan and thyA-spec antibiotic selection cassettes. While
galK-kan cassette replaced the entire region encoding all the six
miRNAs from one of the repeat regions, thyA-spec cassette that
targeted a shorter region removed all the miRNAs except miR-M9
and miR-M4 from the other repeat region.
For generation of viruses with mutations in all of the miRNAs
within the cluster, we synthesised a gene designed to introduce
mutations into the stem loop structures of each of the six miRNAs
in the cluster 1 without affecting the R-LORF8 frame (Fig. 2). In
the miR-S0 and the miR-SS constructs respectively, one or both
copies of the miRNA locus were replaced with this synthetic gene
sequence, preventing them expressing any of cluster 1 miRNAs.
The revertant miR-W0 and miR** viruses both expressed all the
miRNAs, but in the latter, the introduction of a stop codon is
expected to abolish the translation of R-LORF8. These two
constructs were included to delineate between the functions of
miRNAs and the overlapping R-LORF8 gene. The details of
mutations in each of the individual recombinant viruses are
summarised in Table 1. Reconstitution of the viruses in primary
chicken embryo fibroblast (CEF) transfected with the BAC DNA
demonstrated the infectivity of each of the above constructs.
Demonstration of viral proteins Meq, pp38 and pp14 in CEF
infected with the parent pRB-1B5 and different mutant viruses by
western blotting showed that the mutations did not affect the
expression of these proteins (Fig. 3A). This was further confirmed
by specific staining of Meq and pp38 in the nucleus and cytoplasm
respectively of CEF infected with a selection of the mutant viruses
(Fig. 3B). Moreover, analysis of the in vitro growth kinetics showed
very similar replication kinetics for both the parent and mutant
viruses (Fig. 4A) indicating that these miRNAs are not essential for
replication of MDV in vitro. For further analysis of the effect of
mutations in the miRNA cluster on MDV gene expression, we
compared the relative levels of ICP4 and Meq transcripts by
quantitative RT-PCR in CEF infected with the wild type RB-1B,
parent pRB-1B5 and the mutant viruses. MDV-transformed
lymphoblastoid cell line 265L and CEF infected with the Meq-
deletion mutant (RB-1BDMeq) virus were used as controls. These
studies showed that the transcription of ICP4 and Meq were not
affected by mutations in the miRNA locus (Fig. 5A–B), although
the levels of ICP4 transcripts were low with variations among
different viruses in comparison to the Meq transcripts.
In order to examine whether these miRNAs are essential for
MDV replication in vivo, we asked whether viruses with mutations
in the miRNA locus could be re-isolated from birds in later stages
of infection. Successful isolation of MDV by co-culturing of the
peripheral blood leukocytes (PBL) of birds infected with different
viruses 7–8 weeks after infection confirmed that the mutations in
the miRNA locus did not affect the viral replication and their
ability to establish latent infection in vivo. Moreover, quantitative
RT-PCR data of Meq, LAT and ICP4 transcripts in CEF co-
cultured with the PBL from infected birds (Fig. 5C) indicated that
the modifications in the miRNA locus did not affect the expression
of these transcripts in viruses isolated from these birds. All these
results confirmed that the miRNAs encoded from this locus did
not affect MDV replication either in vitro or in vivo.
Deletion of cluster 1 miRNAs abolishes oncogenicity of
the virus
Having shown that the mutations in the miRNA locus did not
affect the replication and viral gene expression in vitro or the
Author Summary
MicroRNAs (miRNAs), encoded in the genomes of a number
of organisms including several viruses, belong to a class of
small RNA molecules that can function as key regulators of
gene expression influencing various biological processes
and diseases including cancer. Among all the miRNAs, miR-
155 has been well documented for its direct role of
oncogenesis in a number of species including chickens.
Remarkably, miR-K12-11 and miR-M4, the miRNAs encoded
by the oncogenic Kaposi’s sarcoma-associated herpesvirus
(KSHV) and Marek’s disease virus (MDV) respectively, have
been shown to be functional orthologs of miR-155. There
are no animal models of KSHV-induced tumors to examine
the oncogenic potential of miR-K12-11. However, using
recombinant mutant viruses in excellent models of MDV-
induced lymphomas in their natural chicken hosts, we
demonstrate that miR-M4 is critical for the induction of
tumors. This is the first study that clearly demonstrates a
directrole forasinglemiRNAininducing cancerinaninvivo
animal model. The ability of gga-miR-155 to rescue the
oncogenic potential of miR-M4-deleted virus demonstrated
the conservation of oncogenic functions the two miRNAs.
Moreover, we show that virus attenuated by deleting the
miRNAs can function as vaccines against virulent virus
infection, enabling the prospects of generating novel
molecularly-defined vaccines.
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miRNAs encoded within this cluster are associated with the
oncogenicity of the virus using the established infection models in
the natural chicken hosts [29]. Compared to the 100 percent
incidence of MD in birds infected with the parent pRB-1B5 virus
(Fig. 6A), none of the birds infected with the miR-00, miR-S0 and
miR-SS viruses developed any gross or microscopic lesions of MD,
showing that the loss of expression of the cluster 1 miRNAs
directly affected the oncogenic potential of MDV. Rescue of the
oncogenic phenotype by the revertant miR-W0 virus to the levels
close to that of the parent virus, even by restoring only one copy of
the miRNA cluster, provided the strong evidence on the distinct
role of these miRNAs in the induction of lymphomas. Moreover,
the induction of MD in 90% of the birds by the miR** virus
(Fig. 6A) demonstrated that miRNAs, but not R-LORF8, are
involved in the induction of lymphomas.
MDV miR-M4 is essential for oncogenicity
Having demonstrated that the miRNAs encoded in the cluster 1
are essential for the oncogenic potential of the virus, we wanted to
refine our investigation to identify whether any single miRNA
within this cluster plays a more important role in the oncogenic
potential of the virus. Since MDV miR-M4 in this cluster is a
functional ortholog of the oncogenic miR-155 [19] implicated in a
number of neoplastic disorders [23], we decided to focus on this
particular miRNA. For this, we used the modified pRB1B5 clone
[30] to generate two additional mutant viruses where only the
miR-M4 was made non-functional. These included the constructs
miR-4-00, where both copies of the pre-miR-M4 sequences were
deleted, and the miR-4-0-mu2, where one of the deleted copies
was replaced with a mutant miR-M4 carrying a 2-nucleotide
mutation in the seed sequence (Fig. 7). We have previously shown
that this mutation in the seed region abolished miR-M4 function
[19]. We also determined the complete sequence of the ,178-kb
genome of the miR-4-0-mu2 construct by deep sequencing and
ruled out unintended mutations or rearrangements generated
during the BAC manipulation. Revertant construct miR-4-0-R
was also generated by restoring one copy of the wild type miR-M4
sequence. A summary of the miRNA expression profiles of these
constructs are in Table 1. The mutant viruses showed similar
growth kinetics in CEF further demonstrating that miR-M4
deletion did not affect replication in vitro (Fig. 4B).
We also examined the expression levels of MDV-encoded
miRNAs miR-M4, miR-M5 and miR-M6 by qRT-PCR on RNA
extracted from CEF infected with wild type RB-1B, the parent
pRB-1B5 and the different mutant viruses (Fig. 8A–C). MDV-
transformed cell line 265L and RB-1BDMeq virus were used as
controls. The absence of miR-M4 and miR-M5 transcripts in the
cells infected by miR-S0 and miR-SS viruses (the low level of miR-
M4 but not miR-M5 in miR-00 virus is due to the presence of one
copy of miR-M4), confirmed the deletion of these miRNAs in
these constructs (Fig. 8A,B). As expected, the expression of miR-
M6 located within the LAT region was not affected by the
mutations within the cluster 1 miRNA locus (Fig. 8C).
When the oncogenicity of these viruses was evaluated in MD
lymphoma model in the natural chicken hosts, the parent pRB-
1B5 virus induced 100 percent disease (Fig. 6B). Compared to this,
none of the birds infected with miR-4-0mu2 virus showed any
clinical evidence, gross tumors or microscopic lesions in any of the
organs. There was 90% reduction of MD incidence in birds
infected with miR-4-00 virus (Fig. 6B), clearly demonstrating the
important role of miR-M4 in inducing lymphomas. The rescue of
the oncogenic phenotype in 70% of birds by the revertant miR-4-
0R virus even by restoring one copy of the wild type of miR-M4,
further confirmed the significant role of miR-M4 in the induction
of lymphomas.
Oncogenic function of miR-M4-deleted virus can be
rescued by gga-miR-155
Since miR-M4 is a functional ortholog of the host-encoded gga-
miR-155 [19], we wanted to examine whether gga-miR-155 can
replace the oncogenic function of miR-M4 in MDV. For this, we
Figure 1. Genome structure of MDV showing positions of the miRNAs. Schematic illustration of the MDV genome structure with the TRL
(terminal repeat long), IRL (internal repeat long), TRS (terminal repeat short) and IRS (internal repeat short) regions, with the positions of the miRNAs
encoded within the 3 clusters. The position and the orientation of the viral genes RLORF8, Meq, RLORF5a, LAT and ICP4 that overlap the miRNA loci
are indicated. Identical copies of the miRNAs in two orientations in the terminal and internal repeat regions are indicated in continuous and dotted
lines.
doi:10.1371/journal.ppat.1001305.g001
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which gga-miR-155 pre-miRNA including the loop sequence of
the chicken BIC transcript [32] was introduced in the position of
the viral miR-M4 pre-miRNA. After demonstrating that the in vitro
growth kinetics on CEF was similar (Fig. 4B), we examined the
oncogenic potential of miR-4-0-155 virus in the MD lymphoma
models in chickens. Demonstration of the incidence of MD at
similar levels (70%) in birds infected with miR-4-0-155 virus and
the miR-4-0R revertant virus (Fig. 6B) indicated that gga-miR-155
can function as an oncogenic miRNA in the context of the MDV
cluster 1 miRNAs. Although the levels of MD incidence were
similar, the onset of tumors induced by miR-4-0-155 virus was
slow, with most of the tumors detected much later than those
induced by the parent pRB-1B5 or the miR-4-0R revertant viruses
(Fig. 6B). Tumours induced by the mutant viruses, including the
chimeric miR-4-0-155 virus, were typical MD lymphomas with
neoplastic lymphoid lesions in multiple organs (Fig. 9A). In order
to demonstrate the expression of gga-miR-155 or miR-M4 in the
tumors induced by miR-4-0-155 and miR-4-0-R viruses respec-
tively, we carried out quantitative RT-PCR on RNA samples
Figure 2. Mutations in the sequences of the miRNAs in the cluster. (a) The sequence of the cluster 1 miRNA locus (nucleotides 134782–
136187) in the MDV genome from the pRB-1B5 virus (GenBank Accession EF523390) showing the positions of the pre-miRNA sequence of the 6
miRNAs (shown in red) encoded within this region. (b) Sequence of the synthetic gene of the corresponding region with mutated sequences of each
of the miRNAs (shown in red and underlined). Mutations were chosen not to alter the predicted open reading frame of the R-LORF8 gene that
overlaps this region.
doi:10.1371/journal.ppat.1001305.g002
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mortem. Demonstration of expression of miR-M4, but not gga-miR-
155, in lymphoid tumors harvested from birds infected with miR-
4-0-R virus (bird numbers #2166S, 2171S, 2172S and 2178K)
indicated the direct correlation between the expression of miR-M4
and the induction of lymphomas (Fig. 9B–C). Despite the low
levels of expression, detection of gga-miR-155 but not miR-M4 in
tumors of birds infected with miR-4-0-155 virus (bird numbers
#2153L, 2153S, 2163L and 2183S) by quantitative RT-PCR and
Northern blotting (Fig. 9D) suggested a direct role for gga-miR-
155 in induction of these tumors.
Attenuated MDV deleted in miRNAs can serve as
effective vaccine
Demonstration of the total loss of oncogenicity persuaded us to
investigate whether MDV made non-oncogenic by inactivation of
miRNAs can function as effective vaccines against virulent MDV
infection. For this, groups of birds were vaccinated with a
recombinant (pCVI988-10) clone [33] of the widely used CVI988
vaccine strain or miR-SS virus that has mutations in all the
miRNAs encoded from both copies of the cluster 1. Birds from all
the groups were challenged with the very virulent plus MDV
(vv+MDV) strain 675A along with unvaccinated controls.
Comparison of the incidence of MD in the 3 groups during the
68-day experimental period showed that miR-SS virus provided
the same level of protection as the widely used Rispens vaccine
against infection by the vv+MDV strain 675A that induced 100
per cent disease in unvaccinated chickens (Fig. 10).
Discussion
Despite the increasing evidence of the potential role of
herpesvirus-encoded miRNAs functioning as determinants of
oncogenicity [34], direct role of any of these miRNAs in the
induction of tumors in vivo has not yet been demonstrated. Using
lymphoma models in the natural chicken hosts infected with
modified recombinant viruses generated from infectious BAC
clones of the oncogenic RB-1B strain of MDV, our study provides
the first direct evidence of the role of miRNAs in the induction of
tumors. The total abolition of tumors in birds infected by viruses
that do not express miRNAs in cluster 1, and subsequent rescue of
the oncogenic phenotype by the revertant miR-W0 virus
demonstrated the direct role of these miRNAs in the induction
of MD lymphomas. Moreover, the inability of miR-S0 and miR-
SS viruses to induce lymphomas and restoration of the oncogenic
phenotype by miR** virus revealed that the miRNAs, and not the
overlapping R-LORF8 gene, are the major determinants of
oncogenicity. Important role of these miRNAs in oncogenesis is
supported by the high levels of their expression in MD tumors and
transformed cell lines [16,18].
Although other miRNAs encoded within this cluster might be
contributing to the induction of MD lymphomas [35], we focussed
mainly on examining the role of miR-M4 for various reasons.
Firstly, MDV miR-M4 is expressed at very high levels in
lymphomas, in some cases accounting for even up to 72% of all
MDV-encoded miRNAs [16,17,18], supporting its potential as a
major determinant of MDV oncogenicity. Secondly, based on the
seed sequence homology and the potential for regulating common
targets such as Pu.1, BACH1, CEBPb, HIVEP2, BCL2L13 and
PDCD6, we have previously shown that miR-M4 is a functional
ortholog of gga-miR-155 [19], a miRNA known to be directly
associated with several cancers [23,36] and molecular mechanisms
of cancer pathogenesis [25,26]. Finally, overexpression of miR-155
has been shown to be associated with lymphocyte transformation
by viruses such as EBV [37] and reticuloendotheliosis virus strain
T [38]. Significant reduction in the incidence of MD in birds
infected with miR-4-00 virus, and the total loss of oncogenicity of
miR-4-0-mu2 virus clearly indicated that miR-M4 plays a critical
role in the induction of MD lymphomas. Although we have not
carried out similar investigations on other miRNAs in this cluster,
the dramatic suppression of oncogenicity subsequent to the loss of
miR-M4 function to the levels similar to those shown by viruses
with mutations in the whole cluster 1 miRNAs, suggested that
miR-M4 is very important for the oncogenicity of MDV. However
the expression of miR-M4 alone appeared to be not sufficient since
miR-00 virus expressing low levels of miR-M4 (Fig. 8A) remained
non-oncogenic, suggesting the contribution of other miRNAs in
the cluster to the oncogenicity. This is also supported by our recent
observation that viruses deleted in miR-M5, another miRNA
within this cluster, retained oncogenicity although not to the same
extent as the wild type viruses (unpublished data). The exact
mechanisms of the loss of oncogenic phenotype by the miR-M4-
deleted/mutated viruses remain to be investigated. However, it is
not due to the lack of expression of viral genes such as Meq, ICP4
Table 1. Profile of the expression of miRNAs and R-LORF8 in different constructs.
IRL TRL
Virus Constructs M9 M5 M12 M3 M2 M4 R-LORF8 M9 M5 M12 M3 M2 M4 R-LORF8
miR-00 2 2 2 2 2 2 2 + 2 2 2 2 + 2
miR-S0 2 2 2 2 2 2 + 2 2 2 2 2 2 2
miR-SS 2 2 2 2 2 2 + 2 2 2 2 2 2 +
miR-W0 + + + + + + + 2 2 2 2 2 2 2
miR ** + + + + + + 2 + + + + + + 2
miR-4-00 + + + + + 2 + + + + + + 2 +
miR-4-0-mu2 + + + + + 2 + + + + + + 2 +
miR-4-0-155 + + + + + 2
{ + + + + + + 2 +
miR-4-0-R + + + + + + + + + + + + 2 +
pRB-1B5 + + + + + + + + + + + + + +
{Expresses one copy of miR-155.
doi:10.1371/journal.ppat.1001305.t001
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proteins or transcripts in infected CEF or PBL (Fig. 3 and 5). It is
also not due to the inability to express miRNAs such as miR-6
outside the cluster 1 (Fig. 8C). MDV miR-M4 is known to
influence directly the expression of a number of viral and cellular
targets [19,22]. The regulation of gene expression by these
miRNAs can also be due to indirect effects, and may include genes
such as Meq. Although the expression levels of Meq in CEF
infected with miR-M4-deleted/mutated viruses were not affected
(Fig. 5B), the relative levels of Meq in the PBL of infected birds
were lower than those from birds infected with viruses expressing
the miRNAs (Fig. 5C). Meq is well-known for its key role in MDV
oncogenesis [11–15]. Although Meq by itself is weak in its
oncogenic potential, modulation of the levels of Meq expression by
these miRNAs could be important in MDV oncogenicity. Our
recent studies have shown that Meq may have a regulatory role in
the expression of cluster 1 miRNAs by binding to its promoter
region (unpublished) suggesting that Meq-miRNA regulatory loop
could be important in the induction of tumors. Thus viral
oncogenesis should be seen as a very complex process involving
the interaction of multiple factors and regulatory processes
including those by the virus-encoded miRNAs. Disruption of
any one of these key elements could have a significant effect on the
oncogenic pathways. Although the precise understanding of all the
molecular processes would need further studies, the present
findings demonstrate that miR-M4, most likely acting through
the miR-155 pathway, functions as a key factor contributing to
MD oncogenesis.
It is remarkable to show that a two-nucleotide mutation in the
miR-M4 seed sequence in the context of the whole viral genome
was sufficient for the total inhibition of oncogenicity of the miR-4-
0-mu2 virus (Fig. 6B). One of the birds (#2168L) infected with
miR-4-00 virus did develop MD lymphoma even in the absence of
miR-M4 (Fig. 9B, C). This is unlikely to be due to any spurious
mutations or recombination events in the virus, as we were able to
confirm the absence of miR-M4 or miR-155 expression in the
tumor tissues of this bird (Fig. 9D). We are yet to identify the exact
mechanisms underlying the development of lymphomas in this
bird in the absence of miR-M4. However, occurrence of such
tumors underlines the complex and multifactorial nature of
oncogenic processes; moreover the individual differences between
birds in immunocompetence and genetic susceptibility could also
contribute to the onset of such tumors. Nevertheless, the near total
elimination of oncogenicity in the absence of miR-M4, and the
rescue of oncogenicity in up to 70 per cent of the birds when the
miR-M4 expression was restored in the revertant miR-4-0-R virus,
provided the first clear evidence on the in vivo role of a virus-
encoded miRNA in the induction of tumors.
The conservation of the seed sequence and the ability to
regulate common sets of targets by miR-M4 and gga-miR-155
[19] prompted us to examine whether the miR-M4 functions of
MDV can be replaced by gga-miR-155. The demonstration of the
ability of the chimeric miR-4-0-155 virus to restore the oncogenic
potential to the same levels as the miR-4-0-R (Fig. 6B), further
demonstrated the significance of the miR-M4/miR-155 pathway
in MD lymphomagenesis. Although the types of tumors induced
by recombinant viruses expressing miR-M4 or gga-miR-155 were
not distinguishable (Fig. 9A), the onset of tumors in birds infected
miR-4-0-155 virus was slow (Fig. 6B), possibly due to the
differences in the functional context of the two miRNAs or in
their processing and expression. This was also evident from the
expression levels of miR-M4 and miR-155 in the primary tumor
samples collected from birds infected with the two viruses.
Compared to the high levels of miR-M4 in tumor samples
induced by miR-4-0-R virus (Fig. 9B), the levels of miR-155 in the
tumors induced by miR-4-0-155 virus were much lower (Fig. 9B).
The lack of expression of miR-M4 and weak expression of miR-
155 in the tumors induced by miR-4-0-155 virus was also
confirmed by Northern blot (Fig. 9D). Interestingly, there is
consistent downregulation of gga-miR-155 in MD tumors and
MDV-transformed cell lines [17,18]. The downregulation of miR-
155 in MDV-transformed tumor cell lines is not a permanent
defect, as these cells can be induced to express miR-155 by co-
infection with retroviruses-expressing v-Rel (unpublished data).
Moreover, recent studies have demonstrated differences between
Figure 3. Expression of viral proteins by the mutant viruses. A)
Western blotting with antibodies against viral antigens Meq (FD7), pp38
(BD1) and pp14 [46] on lysates of CEF infected with the parent pRB-1B5
and the different mutant viruses. MDV-transformed lymphoblastoid cell
line 265L and Meq-deletion mutant RB-1BDMeq were used as controls.
Chicken CtBP1 [11] was used as the loading control. B) Immunofluo-
rescence assay demonstrating the localisation of Meq (red) in the
nucleus (DAPI-stained nucleus shown in blue) and pp38 (green) in the
cytoplasm of CEF on glass cover slips 72 hours after infection with miR-
W0, miR-SS, miR** and miR-S0 viruses.
doi:10.1371/journal.ppat.1001305.g003
Single Virus-Encoded MicroRNA Induces Lymphomas
PLoS Pathogens | www.plospathogens.org 6 February 2011 | Volume 7 | Issue 2 | e1001305miR-M4 and gga-miR-155 in targeting genes such as UL28
despite having identical seed sequences highlighting the signifi-
cance of the non-seed regions of these miRNAs [22]. Tumors
induced by the chimeric miR-4-0-155 virus are the first examples
demonstrating the expression of gga-miR-155 in MD tumors.
Although our study does not identify the various genes linked to
the miR-M4-mediated oncogenesis, demonstration of the signif-
icance of miR-M4 in the induction of lymphomas is a major step
in understanding the molecular oncogenic mechanisms in MD.
From the demonstration of the conserved functions of miR-M4
and miR-155 in the induction of tumors, it is clear that MDV is
able to restore the functions of miR-155 through the expression of
high levels of the functional homolog miR-M4. Although it is
unclear how MDV is able to downregulate miR-155, some
feedback regulatory mechanisms are the most likely mechanisms.
Interestingly in KSHV-induced tumors also, there is upregulation
of the miR-155 functional homolog miR-K12-11, at the expense
of significant downregulation of miR-155 [39]. On the other hand,
EBV does not encode any functional ortholog but induces miR-
155 in transformed B-cells [37], and a recent study has
demonstrated its role in the induction of B-cell transformation
by EBV in vitro [40]. It is unclear what advantages MDV and
KSHV do have in choosing this rather complicated pathway of
encoding and expressing high levels of the functional orthologs of a
host miRNA, the expression of which is repressed in the
transformed cells. One possible advantage of encoding a viral
ortholog is the potential to achieve high levels of expression as seen
in MDV- and KSHV-induced tumors, overriding the tighter
cellular regulatory controls associated with the c-bic/miR-155
expression. Moreover, although miR-155 and the two viral
orthologs may regulate common set of target proteins through
the conserved seed sequences, other potential differences in their
functions, especially due to the differences in the non-seed
sequences, may also exist. It is not known whether the changes
in the non-seed sequences do affect the functions of these miRNAs.
Nevertheless, the differences in the speed in the onset of tumors
between MDV expressing miR-M4 and gga-miR-155 would
suggest that such differences could be important.
The role of miR-M4 and the rescue of the oncogenic phenotype
by miR-155 provide further evidence of the conserved biological
Figure 4. Comparison of the growth kinetics of different viruses. In vitro growth rates of viruses with mutations in the (A) miRNA cluster 1
and (B) miR-M4 locus measured from the viral genome copy numbers determined using TaqMan real-time qPCR on DNA extracted from CEF
harvested at various time points after inoculation. Viral genome copy numbers per 10 000 cells (shown with 95% confidence intervals) are shown on
the y axis.
doi:10.1371/journal.ppat.1001305.g004
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elucidating the functions of other viral orthologs such as KSHV
miR-K12-11. The study also highlights the use of tumor virus
disease models as powerful tools to reveal fundamental molecular
determinants that trigger the development of cancers. Finally, the
demonstration of protection induced by the miR-SS virus against
infection by the vv+MDV strain 675A to the same levels as the
widely used CVI988 vaccine strain (Fig. 10) demonstrated the
prospects of generating molecularly-defined attenuated vaccines
by specific deletion of oncogenic sequences such as the miRNAs.
Materials and Methods
Ethics statement
All animal experiments were performed in accordance with the
United Kingdom Home Office guidelines under the provisions of
the Project License approved by the Institute for Animal Health
Ethical Committee.
Cell culture and reconstitution of recombinant viruses
Primary chicken embryo fibroblast cultures (CEF) were
prepared from 10-day old chicken embryos from SPF eggs as
previously described [29]. Reconstitution of recombinant viruses
was achieved by transfection of 1–2mg BAC DNA into the CEF
using Lipofectamine (Invitrogen).
Construction of viruses with deletion or mutations in
cluster 1 miRNAs
Infectious BAC clone pRB-1B5 [29,30] was used for the
generation of the mutant constructs [41]. List of primers used for
the construction are shown separately (Table S1). Selection markers
galK-kanamycin (galK-Kn) [42] and thymidylate synthase-spectino-
mycin (ThyA-spec) [43] cassettes were used in consecutive steps for
the deletion of the two copies of the miRNA cluster. For this, the
fragment containing the miRNA cluster (GenBank EF523390 -
Nucleotides 134362 to 136848) was amplified with 59 GCCA-
ACTGTACACGCAGGGACGT 39 and 59 GTGCAGTGCC-
TTTGATGTCTG 39 primers and cloned into pCR8-TOPO
vector (Invitrogen). From this vector, the 1665-bp PshAI-StuI
fragment (134527–136183) encompassing all the six miRNAs in
the cluster 1 from miR-M9 to miR-M4 (Fig. 1) was replaced with
galK-Kn cassette to generate the -recombination –construct for
replacing the first copy of the microRNA cluster 1. Similarly, an
XhoI fragment (135221–135959) from this vector was replaced with
a ThyA-spec cassette to make another construct for the specific
replacement of the second copy of the miRNA cluster. This shorter
(783-bp) deletion removed all the miRNAs except miR-M9 and
miR-M4. The two copies of the miRNA cluster were sequentially
deleted using recombineering techniques [41,44] to generate the
miR-00 construct. For generation of viruses with mutations in all of
the miRNAs within the cluster, a 1.45 kb NgoMIV-EcoRV fragment
corresponding to the positions 134785–136216 of the pRB-1B5
sequence was synthesised. The synthetic gene was designed through
alternative codon usage so as to destroy all the pre-miRNA’s hairpin
structures, but retaining the R-LORF8 open reading frame (Fig. 2).
The first copy of the miRNA cluster 1 was replaced using a RecA-
based strategy [28]. Recombinant clones detected by PCR (primers
59 GTAGTGTATCGGTCTTCGTG 39 and 59 CCCGAATA-
CAAGGAATCCTG 39) were digested with BglII to identify the
clones with the replaced synthetic sequence that contained a unique
Figure 5. MDV gene expression in infected cells. Relative
expression of MDV gene ICP4 (A) and Meq (B) measured by qRT-PCR
(normalised to the GAPDH levels) in RNA extracted from CEF infected
with the wild type RB-1B, the parent pRB-1B5 and the different mutant
viruses. Uninfected CEF, MDV-transformed lymphoblastoid cell line 265L
and Meq-deletion mutant RB-1BDMeq were used as controls. (C)
Relative expression levels of Meq, ICP4 and LAT in CEF co-cultured with
the PBL collected from birds infected with different viruses. The relative
expression levels of Meq normalised to ICP4 (blue) and LAT transcripts
(red) are shown. Results represent mean of triplicate assays with error
bars showing the standard errors of the mean. The identification
number of individual birds infected with miR-SS (No. 1 & 4), miR**
(No. 12 & 20), miR-W0 (No. 25 &30) and miR-S0 (No. 74 & 77) are shown.
doi:10.1371/journal.ppat.1001305.g005
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of the miRNA cluster replaced with the synthetic sequence and the
other copy deleted by the insertion of the galK-kn was designated
miR-S0. The galK-kn selection marker in the miR-S0 construct was
then replaced with the pKOV-miR-syn construct to generate the
construct with both copies of the miRNA cluster 1 replaced by
synthetic sequences, and named miR-SS. We also generated a
revertant construct miR-W0, in which we replaced one copy of wild
type miRNA cluster sequence from pRB-1B5, while the other copy
remains deleted. We mutated one copy of R-LORF8 start codon by
inserting FRT-Kn cassette amplified by PCR using R-LORF8-Kn-
For and R-LORF8-Kn-Rev primers (Table S1). The FRT-Kn
cassette was ‘Flipped-off’ in E coli strainSW105, leaving only a ‘scar’
sequence. In order to prevent the translation of R-LORF8, we
introduced stop codon replacing the ATG initiation codon in the
constructmiR**.Forthis,we firstdestroyedthegene by introducing
the galK-kn cassette into the locus. This was then replaced with a
modified R-LORF8 sequence generated by PCR using R-LORF8-
stop-For and R-LORF8-stop-Rev primers (Table S1). Detailed
protocols for the manipulation of the BAC constructs are provided
separately [41]. The accuracy of the mutations in different
constructs was checked by sequencing.
Construction of viruses with deletion or mutations of
miR-M4
In order to examine the role of miR-M4 in MDV oncogenicity,
we also constructed a series of viruses with mutations only in the
miR-M4, by standard mutagenesis techniques [45] on the pRB-
1B5 clone [29]. First we deleted one copy of the pre-miR-M4 with
FRT-Kn cassette using PCR product derived with miR-M4-kn-
For and miR-M4-kn-Rev primers. After excision of the Kn
cassette, the second copy was deleted with galK cassette using PCR
products derived with miR-M4-galK-For and miR-M4-galK-Rev
primers. This construct with deletion of both copies of the miR-
M4 was designated miR-M4-00 and the galK locus in this
construct was used for generating additional constructs. For the
Figure 6. Incidence of MD in birds infected with recombinant viruses. Survival rates based on the morbidity and cumulative incidence of MD
in SPF line P (B
21/21) birds during the experimental period in groups of birds infected with (A) parent pRB-1B5 and mutant derivatives miR-00, miR-S0,
miR-SS, miR-W0 and miR** and (B) parent pRB-1B5 and mutant derivatives miR-4-00, miR-4-0-mu2, miR-4-0-155 and miR-4-0-R. The incidence was
determined from occurrence of MD determined at post mortem from gross or histopathological lesions of lymphomas.
doi:10.1371/journal.ppat.1001305.g006
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product with miR-M4-mu2-Top and miR-M4-mu2-Bottom
primers, designed to introduce two-nucleotide mutations in the
miR-M4 seed region that has been previously shown to be
sufficient to abolish the function of miR-M4. The galK selection
marker in the miR-M4-00 construct was replaced with the
mutated miR-M4 to generate the miR-4-0-mu2 construct. In
order to generate another construct in which the miR-M4 was
replaced with the miR-155 sequence, we generated the gga-miR-
155 pre-miRNA along with the loop sequence using miR-M4-155-
Top and miR-M4-155-Bottom primers. The galK selection marker
in the miR-4-00 construct was replaced with the annealed above
oligonucleotides to generate the miR-4-0-155. Finally, the
revertant construct miR-4-0-R was generated in which the wild
type miR-M4 sequence was restored. The accuracy of all the
modifications was also confirmed by sequencing the modified
regions of the constructs. The whole genome of the miR-4-0-mu2
was determined by deep sequencing to confirm the mutations and
to rule out any unexpected mutations or recombinations.
Virus infection studies in vivo
All animal experiments were carried out under licence from the
UK Home Office in dedicated negative pressure rooms. Groups
(n=10–12) of one day-old line P (MHC type B
19/B
19)c h i c k sw e r e
infected with 1,000 plaque forming units (pfu) of miR-00, miR-S0,
miR-SS, miR-W0, miR**, miR-4-00, miR-4-0-mu2, miR-4-0-155
and miR-4-0-R and pRB1B5 viruses as described. Blood samples
collected at regular intervals or post-infection (d. p. i.) were used for
quantitation of virus load or for the extraction of RNA from the PBL.
Methods for quantitative RT-PCR to measure miRNA/transcript
levels have been described [31]. Virus isolations were also performed
by inoculating 1610
6 PBL to a well of a 6-well plate of CEF and
incubated at 38.5 C in 5% CO2 until the appearance of virus
Figure 7. Sequence and structure of miR-M4 and the mutant
region. (A) The sequence of the mature miR-M4 with the region of the
seed region underlined and shown in red. The corresponding region of
the miR-4-0-mu2 mutant, with the two nucleotide changes in the seed
region is shown in blue. (B) The predicted stem loop structure of (a) the
pre-miR-M4 and (b) the mutant with the two nucleotide changes in the
seed region (shown in blue). The sequence of the mature miRNA
strands is shown in red.
doi:10.1371/journal.ppat.1001305.g007
Figure 8. Expression of miR-M4, miR-M5 and miR-M6 in
infected cells. Relative expression of (A) miR-M4, (B) miR-M5 and
(C) miR-M6 measured by qRT-PCR in RNA extracted from CEF infected
with the wild type RB-1B, the parent pRB-1B5 and each of the mutant
viruses. Uninfected CEF, MDV-transformed lymphoblastoid cell line 265L
and Meq-deletion mutant RB-1BDMeq were used as controls. The
lowest level of positive samples in each group (miR-00 for miR-M4, miR-
4-0-mu2 for miR-M5 and miR-M6) was used as calibrator. Results
represent the mean of triplicate assays with error bars showing the
standard error of the mean.
doi:10.1371/journal.ppat.1001305.g008
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clinical end-points and samples taken post-mortem for histology.
Birds showing gross or histological lesions of lymphomas in any of the
tissues collected at post-mortem were diagnosed as MD-positive, and
the data from the incidence of MD from eachof the groups wereused
to calculate the cumulative survival rates.
Vaccination and challenge studies
Groups (n=10) of one-day old birds were vaccinated via the
intra-muscular route with either sham vaccine, or 925 pfu of miR-
SS or pCVI988 viruses. One week after infection, all the birds were
infected with 1450 pfu of the vv+MDV strain 675A via the intra-
peritoneal route. Birds wereobserved for the onset ofclinical disease
and the incidence of MD was recorded up to 68 days post infection.
All the birds were necropsied at the end of the experiment and the
incidence of MD from the gross and microscopic lesions was used to
calculate the survival rates from virus infection.
Detection of viral antigens
Western blotting to detect the viral proteins Meq, pp38 and
pp14, and the chicken CtBP1 was carried out using methods
previously described [11]. Immunofluorescence staining and
Figure 9. Pathological lesions and expression of miRNAs in tumors induced by MDV. (A) Pathology of MD lymphomas induced by
different viruses in infected birds: Gross lesion showing lymphoma of the right testis (a) and histological lesions of lymphoma of the testis (b) and
skeletal muscle (c) of birds infected with the parent pRB-1B5 virus; histological lesions of lymphomas in the cardiac muscle (d), and liver (e) in a bird
infected with miR** virus; histological lesions of lymphoma of the liver (f) and skeletal muscle (g) in birds infected with miR-4-0-R virus; Gross lesions
of the liver showing lymphomas (h) in the bird (#2163) infected with miR-4-0-155 virus. (Haematoxylin & Eosin stain, Bar=50mM). (B) Relative
expression of miR-M4 (normalised with the levels of miR-M8) in RNA extracted from tumor tissues induced by miR-4-0-155 (samples 2153L, 2153S,
2163L and 2183S), miR-4-0-R (samples 2166S, 2171S, 2172S and 2178K) and miR-4-00 (sample 2168L). As expected, none of the tumors from birds
infected with miR-4-0-155 virus showed miR-M4 expression, while all the miR-4-0-R virus-induced tumors did show high levels of miR-M4 expression.
(C) Relative expression of miR-155 (normalised to the let-7) in the above tumor tissues showed increased levels of miR-155 in the miR-M4-0-155 virus-
infected tumors, but not in any of the miR-M4-0R virus-infected tumor tissues. No expression of miR-M4 but very low miR-155 was detected in the
tumor that was induced in a single bird (2168L) infected with miR-M4-00 virus. (D) Confirmation of the expression of miR-155, but not miR-M4, in the
miR-M4-0-155 virus-infected tumor tissues of samples by Northern blot analysis. The cellular U6 small nuclear RNA served as a loading control.
doi:10.1371/journal.ppat.1001305.g009
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glass coverslips infected with the mutant viruses using methods
described [12]. The infected cell were fixed in 4% paraformalde-
hyde, permeabilised with 0.1% Triton x-100 and stained with anti-
Meq antibody (FD7) or anti-pp38 (BD1) antibodies and detected
with Alexa Fluor 488/568-conjugated goat anti-mouse reagents
(Invitrogen). Images were taken using Leica TCS SP5 confocal
laser scanning microscope.
Supporting Information
Table S1 List of oligonucleotides used in the experiments.
Found at: doi:10.1371/journal.ppat.1001305.s001 (0.04 MB
DOC)
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